High-dose methotrexate vs. Capizzi methotrexate for the treatment of childhood T-cell acute lymphoblastic leukemia

Sixty-three children (1–14 years of age) newly diagnosed with T-cell acute lymphoblastic leukemia were treated from January 2001 to December 2014. Patient outcomes were evaluated based on the regimen received; Capizzi methotrexate (C-MTX) vs. high-dose methotrexate (HDMTX). Complete remission (CR) w...

Descripción completa

Detalles Bibliográficos
Autores principales: Jastaniah, Wasil, Elimam, Naglla, Abdalla, Khalid, AlAzmi, Aeshah A., Aseeri, Mohammed, Felimban, Sami
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6215054/
https://www.ncbi.nlm.nih.gov/pubmed/30416957
http://dx.doi.org/10.1016/j.lrr.2018.10.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6215054/
https://www.ncbi.nlm.nih.gov/pubmed/30416957
http://dx.doi.org/10.1016/j.lrr.2018.10.001

Ejemplares similares